Please login to the form below

Not currently logged in

The world needs exemplary leaders

Demographic shifts are creating demand for exemplary leadership that exceeds supply

Study finds no problems switching from Remicade to biosimilar

Findings look to dispel ‘biosimilar resistance’ and encourage greater uptake

UK to cut wait to innovative treatments by four years

Proposals in the Accelerated Access Review aim to speed up access to innovation

Lilly promises solanezumab news in Alzheimer's 'before year-end'

Eli Lilly HQIf anti-amyloid drug proves effective, sales could reach $7.5bn according to analysts

Novartis says its biosimilar sales should reach $1bn this year

Novartis Gehry Building, Basel, SwitzerlandFour-drug portfolio grew by 40% to $262m in the quarter

Merck gets early OK for Keytruda in first-line lung cancer

Merck and Co - US headquartersFDA fast-tracks approval of PD-1/PD-L1 inhibitor for treatment of NSCLC

GSK's blockbuster hopeful Shingrix filed in US

GSK - logo on buildingClinical data showed shingles vaccine had 90% efficacy in elderly patients

Pharma 'could do better' on social media engagement

Industry is comfortable with the tech but has work to do on its approach

What does good marketing look like in 2016?

Promotion does not act within a vacuum, so knowing and measuring your environment is a critical success factor

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Access to orphan drugs for rare cancers in EU28
Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...